Cargando…

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment

Metaplastic breast carcinoma (MBC) differs from classic invasive ductal carcinomas regarding incidence, pathogenesis, and prognosis. The purpose of this study was to compare patients with MBC with clinicopathologic and treatment-matched patients with triple-negative breast carcinoma (TNBC) in terms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aydiner, Adnan, Sen, Fatma, Tambas, Makbule, Ciftci, Rumeysa, Eralp, Yesim, Saip, Pinar, Karanlik, Hasan, Fayda, Merdan, Kucucuk, Seden, Onder, Semen, Yavuz, Ekrem, Muslumanoglu, Mahmut, Igci, Abdullah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291613/ https://www.ncbi.nlm.nih.gov/pubmed/26717372 http://dx.doi.org/10.1097/MD.0000000000002341

Ejemplares similares

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer
por: Cabioglu, Neslihan, et al.
Publicado: (2021)

Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery
por: Karanlik, Hasan, et al.
Publicado: (2015)

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer
por: Cabioglu, Neslihan, et al.
Publicado: (2023)

Comparison of Pathological Prognostic Stage and Anatomic Stage Groups According to the Updated Version of the American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8(th) Edition
por: Ibis, Kamuran, et al.
Publicado: (2018)

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Sen, Fatma, et al.
Publicado: (2016)

Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
por: Oner, Gizem, et al.
Publicado: (2021)

Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
por: Oner, Gizem, et al.
Publicado: (2023)

Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up
por: Özkurt, Enver, et al.
Publicado: (2018)

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
por: Emiroglu, Selman, et al.
Publicado: (2023)

High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated/dedifferentiated carcinomas of the endometrium: An immunohistochemical and clinicopathologic study
por: Onder, Semen, et al.
Publicado: (2017)

Breast cancer risk factors in Turkish women – a University Hospital based nested case control study
por: Ozmen, Vahit, et al.
Publicado: (2009)

Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group
por: Dogan, Izzet, et al.
Publicado: (2023)

High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer
por: Mollavelioglu, Baran, et al.
Publicado: (2022)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
por: Kizildag Yirgin, Inci, et al.
Publicado: (2020)

Is Surgical Treatment an Option for Locally Advanced Cervical Cancer in the Presence of Central Residual Tumor after Chemoradiotherapy?
por: Topuz, Samet, et al.
Publicado: (2020)

Multimodality imaging and histopathology of metaplastic breast cancer
por: Çelik, Hakkı, et al.
Publicado: (2023)

Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
por: Dogan, Izzet, et al.
Publicado: (2023)

Is the thymidine labeling index a good prognostic marker in breast cancer?
por: Sen-Oran, Ebru, et al.
Publicado: (2007)

Renin-Angiotensin System Blockers May Prolong Survival of Metastatic Non-Small Cell Lung Cancer Patients Receiving Erlotinib
por: Aydiner, Adnan, et al.
Publicado: (2015)

Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy
por: GEZER, UGUR, et al.
Publicado: (2014)

The Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of Janus
por: Eralp, Yesim
Publicado: (2016)

Is there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?
por: Yildiz, Yemliha, et al.
Publicado: (2010)

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
por: Lien, Huang-Chun, et al.
Publicado: (2023)

TWIST1 Gene Expression as a Biomarker for Predicting Primary Doxorubicin Resistance in Breast Cancer
por: Demir, S, et al.
Publicado: (2019)

Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma
por: Qiu, Yue, et al.
Publicado: (2022)

Metaplastic Breast Cancer: To Radiate or Not to Radiate?
por: Tseng, Warren H., et al.
Publicado: (2010)

Treatment Options for Metaplastic Breast Cancer
por: Shah, Dhruvil R., et al.
Publicado: (2012)

Metaplastic carcinoma of the breast: an immunohistochemical study
por: Altaf, Fadwa J, et al.
Publicado: (2014)

Metaplastic breast cancer with chondroid differentiation
por: Myint, Zin W., et al.
Publicado: (2015)

Human Metaplastic Breast Carcinoma and Decorin
por: Boström, Pia, et al.
Publicado: (2017)

Clinical utility of a 1.5 T magnetic resonance imaging-guided linear accelerator during conventionally fractionated and hypofractionated prostate cancer radiotherapy
por: Turkkan, Gorkem, et al.
Publicado: (2022)

A Phantom Study on Fetal Dose Reducing Factors in Pregnant Patients with Breast Cancer during Radiotherapy Treatment
por: Öğretici, Akın, et al.
Publicado: (2017)

Metaplastic Carcinoma of the Breast with Neuroectodermal Stromal Component
por: Tot, Tibor, et al.
Publicado: (2011)

Metaplastic Carcinoma with Predominant Chondrosarcoma of the Right Breast
por: Bhosale, S.J., et al.
Publicado: (2010)

Diagnostic utility of snail in metaplastic breast carcinoma
por: Nassar, Aziza, et al.
Publicado: (2010)

Metaplastic carcinoma of the breast with rhabdo-myosarcomatous element
por: Anand, Mani, et al.
Publicado: (2014)

Metaplastic Breast Cancer in a Patient with Neurofibromatosis
por: Chaudhry, Umar Shafique, et al.
Publicado: (2015)

Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast
por: Piscuoglio, Salvatore, et al.
Publicado: (2017)

Role of RPL39 in Metaplastic Breast Cancer
por: Dave, Bhuvanesh, et al.
Publicado: (2017)

Hypercalcemia in Metaplastic Squamous Cell Carcinoma of the Breast
por: Hardy, Brendan M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_odfq8drc6rdttr47qjn9ij9qgp